PD-1 Relevant Genes Predict the Prognosis of Breast Cancer and Their Prediction Effect in Tumor Response to Immunotherapy
Author:
Publisher
Walter de Gruyter GmbH
Subject
Oncology
Link
https://www.techscience.com/oncologie/v24n4/51001/pdf
Reference42 articles.
1. Pembrolizumab in patients with advanced triple-negative breast cancer: Phase Ib KEYNOTE-012 study;Nanda;Journal of Clinical Oncology,2016
2. First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis;Emens;Annals of Oncology,2021
3. Safety and antitumor activity of pembrolizumab in patients with estrogen receptor-positive/Human epidermal growth factor receptor 2-negative advanced breast cancer;Rugo;Clinical Cancer Research,2018
4. Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: A phase 1b JAVELIN solid tumor study;Dirix;Breast Cancer Research and Treatment,2018
5. B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer;Hollern;Cell,2019
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revealing Cellular Heterogeneity and Key Regulatory Factors of Triple-Negative Breast Cancer through Single-Cell RNA Sequencing;Frontiers in Bioscience-Landmark;2024-08-19
2. Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma;Scientific Reports;2024-07-31
3. Identification of Molecular Subtypes Associated with PCD in Esophageal Squamous Cell Carcinoma and Analysis of Immune Microenvironment;Current Medicinal Chemistry;2024-05-10
4. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers;Scientific Reports;2024-04-30
5. Research on a machine learning-based adaptive and efficient screening model for psychological symptoms of community correctional prisoners;Scientific Reports;2024-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3